文献速递头颈部肿瘤放疗放疗物理与技术

动态承载容量模型预测头颈癌放疗个体反应

Forecasting Individual Patient Response to Radiation Therapy in Head and Neck Cancer With a Dynamic Carrying Capacity Model.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2021-06-05

本研究将肿瘤动力学建模为逻辑增长,并将放疗效应建模为肿瘤承载容量的降低,在MCC和MDACC两个独立头颈癌队列的每周肿瘤体积数据上评估。模型以患者特异性δ和固定肿瘤生长率高精度拟合MCC数据,并利用MCC学习的生长率以相当精度拟合MDACC数据,显示生长率可迁移。纳入4次治疗中肿瘤体积测量时,预测框架对局部区域控制的敏感性和特异性分别为76%和83%,对无病生存分别为68%和85%。

要点

  • 逻辑增长与承载容量降低模型可高精度拟合头颈癌放疗中肿瘤体积动态。
  • 从MCC学习的肿瘤生长率可迁移至MDACC独立队列并保持相当拟合精度。
  • 纳入4次治疗中体积测量可预测局部区域控制与无病生存。

核心结论

  • 简单数学模型可描述多种肿瘤体积动态,结合历史反应与少量患者特异性体积测量可准确预测结局并可能支持治疗适应与个体化。

研究设计与样本

  • 研究基于MCC和MDACC两个独立头颈癌患者队列的每周肿瘤体积数据,患者接受66至70 Gy标准每日分割或加速分割放疗。

主要发现

  • 模型以患者特异性δ和所有患者固定肿瘤生长率高精度拟合MCC数据。
  • 使用MCC学习的肿瘤生长率,模型以相当精度拟合MDACC独立队列数据,显示生长率可迁移。
  • 纳入4次治疗中肿瘤体积测量时,预测框架对局部区域控制的敏感性76%、特异性83%,对无病生存的敏感性68%、特异性85%。

关键数值与推荐

  • 放疗剂量为66至70 Gy,采用标准每日分割或加速分割。
  • 预测局部区域控制敏感性76%、特异性83%;预测无病生存敏感性68%、特异性85%,均基于纳入4次治疗中肿瘤体积测量。

临床怎么用

  • 可利用治疗中少量肿瘤体积测量结合模型预测个体患者放疗结局,为治疗适应和个体化提供参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To model and predict individual patient responses to radiation therapy. METHODS AND MATERIALS: We modeled tumor dynamics as logistic growth and the effect of radiation as a reduction in the tumor carrying capacity, motivated by the effect of radiation on the tumor microenvironment. The model was assessed on weekly tumor volume data collected for 2 independent cohorts of patients with head and neck cancer from the H. Lee Moffitt Cancer Center (MCC) and the MD Anderson Cancer Center (MDACC) who received 66 to 70 Gy in standard daily fractions or with accelerated fractionation. To predict response to radiation therapy for individual patients, we developed a new forecasting framework that combined the learned tumor growth rate and carrying capacity reduction fraction (δ) distribution with weekly measurements of tumor volume reduction for a given test patient to estimate δ, which was used to predict patient-specific outcomes. RESULTS: The model fit data from MCC with high accuracy with patient-specific δ and a fixed tumor growth rate across all patients. The model fit data from an independent cohort from MDACC with comparable accuracy using the tumor growth rate learned from the MCC cohort, showing transferability of the growth rate. The forecasting framework predicted patient-specific outcomes with 76% sensitivity and 83% specificity for locoregional control and 68% sensitivity and 85% specificity for disease-free survival with the inclusion of 4 on-treatment tumor volume measurements. CONCLUSIONS: These results demonstrate that our simple mathematical model can describe a variety of tumor volume dynamics. Furthermore, combining historically observed patient responses with a few patient-specific tumor volume measurements allowed for the accurate prediction of patient outcomes, which may inform treatment adaptation and personalization.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Zahid MU, Mohsin N, Mohamed ASR, et al. Forecasting Individual Patient Response to Radiation Therapy in Head and Neck Cancer With a Dynamic Carrying Capacity Model. Int J Radiat Oncol Biol Phys. 2021. PMID: 34102299. doi:10.1016/j.ijrobp.2021.05.132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。